ReviewDrugs2023
Mirvetuximab Soravtansine: First Approval.
Young-A HeoPubMed ↗Publisher ↗
No numbers read from the abstract.
59 papers cite it
this paperpooled itcites it
ReviewDrugs2023
Young-A HeoPubMed ↗Publisher ↗
No numbers read from the abstract.